|
Basic data at first dose of IPTi |
||||
| Kumasi cohort |
Lambaréné cohort |
|||
|
|
||||
| SP |
Placebo |
SP |
Placebo |
|
|
|
||||
| Participants, n |
535 |
535 |
504 |
507 |
| Age, mean days (sd) |
90 (± 12) |
89 (± 11) |
96 (± 14) |
97 (± 14) |
| Hb, mean g/dL (sd) |
10.4 (± 1.4)a |
10.3 (± 1.3)b |
10.0 (± 1.2)c |
9.8 (± 1.3)d |
| Anaemiae, % |
2.1a |
2.1b |
0.9c |
2.2d |
| Parasitaemia, geomean/μlf |
681 |
779 |
790 |
1240 |
|
sd, standard deviation, SP, sulphadoxine-pyrimethamine a n = 531 b n = 534 c n = 461 d n = 458 e Hb < 7.5 g/dL f in those parasitaemic | ||||
May et al. Malaria Journal 2008 7:198 doi:10.1186/1475-2875-7-198 |
||||